MK-1006

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for MK-1006, covering 2012-08-20 to 2012-10-10. Get the full timeline:

Most recent: Clinical Trial Update: MK-1006 Single Dose Study in Japanese Type 2 Diabetes Patients (MK-1006-005) [Phase 1]